NIVF — NewGenIvf Cashflow Statement
0.000.00%
Last trade - 00:00- $4.00m
- $6.02m
- $5.43m
Annual cashflow statement for NewGenIvf, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -0.139 | 0.136 | 0.108 | -0.474 |
| Depreciation | ||||
| Non-Cash Items | 0.207 | 0.365 | -0.014 | -0.239 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 1.02 | 0.906 | -2.09 | -7.76 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Change in Taxes Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 1.43 | 1.71 | -1.77 | -8.26 |
| Capital Expenditures | -0.017 | -0.094 | -0.07 | -0.053 |
| Purchase of Fixed Assets | ||||
| Cash from Investing Activities | -0.017 | -0.094 | -0.07 | -0.053 |
| Financing Cash Flow Items | -2.04 | -1.74 | 1.7 | -0.029 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | -1.54 | -1.63 | 1.88 | 8.68 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -0.077 | -0.001 | 0.027 | 0.404 |